Overcoming BRAF/MEK Inhibition Resistance in Anaplastic Thyroid Carcinoma ASPIRE Award (2020-2024) Jennifer Wang, MD (Principal); Mark Zafereo, MD; and Wenyi Wang, PhD, The University of Texas MD Anderson Cancer Center Read More
CBP/p300 Inhibitors for Genetically Defined Leukemias 2020 Drug Discovery Award Philip Jones, PhD, MD Anderson Cancer Center Read More
Cysteine-Modification Screening to Identify Functional and Druggable Sites in Cancer Dependencies Damon Runyon - Mark Foundation Postdoctoral Fellow (2020-Present) Haoxin Li, PhD, The Scripps Research Institute Read More
Uncovering the Mystery of Metastatic Dormancy in Breast Cancer: An Unprecedented View ASPIRE Award (2020-2022) Alana Welm, PhD, University of Utah Read More
Elucidating the Mechanism of Menin-MLL Interaction Inhibition in NPM1c Mutated Acute Myeloid Leukemia Momentum Fellow (2020-2021) Hannah Uckelmann, PhD, Dana-Farber Cancer Institute Read More
Targeting Leukemia Stem Cells by Disrupting Translational Fidelity IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-2024) Robert Signer, PhD, University of California San Diego Read More